Interpretation of lung cancer study outcomes.

about

Interpretation of lung cancer study outcomes.

Item

http://www.wikidata.org/entity/Q38682736

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Interpretation of lung cancer study outcomes.

@en

type

Item

label

Interpretation of lung cancer study outcomes.

@en

prefLabel

Interpretation of lung cancer study outcomes.

@en

P1476

Interpretation of lung cancer study outcomes

@en

P2093

Davide Pelizzoni

http://www.w3.org/2001/XMLSchema#string

Marida Abbate

http://www.w3.org/2001/XMLSchema#string

Paolo Bidoli

http://www.w3.org/2001/XMLSchema#string

Stefania Canova

http://www.w3.org/2001/XMLSchema#string

P2860

A perfect correlate does not a surrogate make

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Detecting an overall survival benefit that is derived from progression-free survival

The BATTLE trial: personalizing therapy for lung cancer.

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials.

P304

E541-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2072-1439.2015.11.26

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diego Cortinovis

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26716052

http://www.w3.org/2001/XMLSchema#string

P932

4669287

http://www.w3.org/2001/XMLSchema#string

Interpretation of lung cancer study outcomes.

about

Interpretation of lung cancer study outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932